Genetic Technologies Limited, often referred to as GeneType, is a pioneering biotechnology company headquartered in Australia. Founded in 2000, the company has established itself as a leader in the field of genetic testing and personalised medicine, with a focus on providing innovative solutions for health management and disease prevention. Operating primarily in Australia and expanding into international markets, Genetic Technologies offers a range of unique genetic testing services. Their flagship product, the GeneType test, empowers individuals with insights into their genetic predispositions, enabling informed health decisions. The company is recognised for its commitment to advancing genetic research and has achieved significant milestones in the development of non-invasive testing methods. With a strong market position, Genetic Technologies Limited continues to drive innovation in the biotechnology sector, contributing to the growing demand for personalised healthcare solutions.
How does Genetic Technologies Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Genetic Technologies Limited's score of 14 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Genetic Technologies Limited, headquartered in Australia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Genetic Technologies Limited may not have established a comprehensive framework for addressing its carbon footprint or climate impact at this time. As the industry increasingly prioritises sustainability, it will be essential for the company to consider developing and communicating its climate commitments to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Genetic Technologies Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
